Literature DB >> 22275494

Explanatory models are needed to integrate RCT and observational data with the patient's unique biology.

Vijay Sharma1, Rubin Minhas.   

Abstract

In this review, we make the case for evidence-based medicine (EBM) to include models of disease underscored by evidence in order to integrate evidence, as it is currently defined, with the patient's unique biology. This would allow clinicians to use a pathophysiologic rationale, but underscoring the pathophysiological model with evidence would create an objective evidence base for extrapolating randomized controlled trial evidence. EBM encourages practitioners not to be passive receivers of information, but to question the information. By the same token, practitioners should not be passive executors of the process by which information is generated, appraised and applied, but should question the process. We use the historical examples of the evolution of EBM to show that its subordination of a pathophysiological perspective was unintentional, and of essential hypertension to illustrate the importance of disease models and the fact that evidence supporting them comes from many sources. We follow this with an illustration of the benefits a pathophysiological perspective can bring and a suggested model of how inclusion of pathophysiological models in the EBM approach would work. From a practical perspective, information cannot be integrated with the patient's unique biology without knowledge of that biology; this is why EBM is currently so silent on how to carry out its fourth stage. It is also clear that, regardless of whether a philosophical or practical definition of evidence is used, pathophysiology is evidence and should be regarded as such.

Entities:  

Mesh:

Year:  2012        PMID: 22275494      PMCID: PMC3265235          DOI: 10.1258/jrsm.2011.110236

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  37 in total

1.  Ethics and EBM: acknowledging bias, accepting difference and embracing politics.

Authors:  Ian Kerridge
Journal:  J Eval Clin Pract       Date:  2010-04       Impact factor: 2.431

Review 2.  Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.

Authors:  Edoardo Camenzind; P Gabriel Steg; William Wijns
Journal:  Circulation       Date:  2007-03-07       Impact factor: 29.690

3.  The effect of sulfanilamide on salt and water excretion in congestive heart failure.

Authors:  W B SCHWARTZ
Journal:  N Engl J Med       Date:  1949-02-03       Impact factor: 91.245

Review 4.  Why have antioxidants failed in clinical trials?

Authors:  Steven R Steinhubl
Journal:  Am J Cardiol       Date:  2008-05-22       Impact factor: 2.778

5.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

6.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

7.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

Review 8.  The etiology of hypertension in the metabolic syndrome part one: an introduction to the history, the concept and the models.

Authors:  Vijay Sharma; John H McNeill
Journal:  Curr Vasc Pharmacol       Date:  2006-10       Impact factor: 2.719

9.  Evidence-based medicine. A tool for enhancing critical care practice.

Authors:  D J Cook; M M Levy
Journal:  Crit Care Clin       Date:  1998-07       Impact factor: 3.598

10.  Justice in health research: What is the role of evidence-based medicine?

Authors:  Wendy Rogers; Angela Ballantyne
Journal:  Perspect Biol Med       Date:  2009       Impact factor: 1.416

View more
  4 in total

1.  Two sides of a coin.

Authors:  Arun S Nanivadekar
Journal:  J R Soc Med       Date:  2012-04       Impact factor: 5.344

2.  Avicenna and the Canon Medicinae.

Authors:  Farhad B Naini
Journal:  J R Soc Med       Date:  2012-04       Impact factor: 5.344

3.  The Ethics of Ironic Science in Its Search for Spoof.

Authors:  Maryam Ronagh; Lawrence Souder
Journal:  Sci Eng Ethics       Date:  2014-12-16       Impact factor: 3.525

Review 4.  Using multiple types of studies in systematic reviews of health care interventions--a systematic review.

Authors:  Frank Peinemann; Doreen Allen Tushabe; Jos Kleijnen
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.